Evidence map›Paper›PMID 25467442›Full record

ArticlemBio2014

Genomics and proteomics of mycobacteriophage patience, an accidental tourist in the Mycobacterium neighborhood.

Welkin H Pope, Deborah Jacobs-Sera, Daniel A Russell, Daniel H F Rubin, Afsana Kajee, Zama N P Msibi, Michelle H Larsen, William R Jacobs, Jeffrey G Lawrence, Roger W Hendrix and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 44 citations in OpenAlex.

  1. Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Whole-genome sequence of subcluster BE1Microbiology resource announcements · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. InvestigatingMolecular & cellular proteomics : MCP · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Welkin H PopeDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Deborah Jacobs-SeraDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Daniel A RussellDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Daniel H F RubinHarvard College, Cambridge, Massachusetts, USA.
Afsana KajeeUniversity of KwaZulu-Natal, School of Laboratory Medicine, College of Health Sciences, Inkosi Albert Luthuli Hospital, Durban, South Africa.
Zama N P MsibiDepartment of Infection Prevention and Control, University of KwaZulu-Natal, Durban, South Africa.
Michelle H LarsenDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
William R JacobsHoward Hughes Medical Institute, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Jeffrey G LawrenceDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Roger W HendrixDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Graham F HatfullDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA gfh@pitt.edu.
University of Pittsburgh · USAlbert Einstein College of Medicine · USUniversity of KwaZulu-Natal · ZAHarvard College Observatory · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
ASSEMBLY AND STRUCTURE OF BACTERIOPHAGE LAMBDAR01GM047795 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUDA, ROBERT LOUIS · 1991 to 2017
$7.8M
Molecular Genetic Analysis of Mycobacterium TuberculosisR37AI026170 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI WILLIAM Robert JACOBS · 2004 to 2026
$7.7M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR01AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 2022
$7.1M
Mycobacteriophage as an emerging model organismR24GM093901 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HATFULL, GRAHAM F. · 2011 to 2014
$1.1M
Genome Evolution in Pathogens: The roles of predator-prey interactionsR01GM077548 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAWRENCE, JEFFREY G · 2007 to 2010
$883k
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR22AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 1991
–
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000005NIAID NIH HHS AI26170NIAID NIH HHS R01 AI026170NIAID NIH HHS R37 AI026170NIGMS NIH HHS GM077548NIGMS NIH HHS GM093901NIGMS NIH HHS GM47795NIGMS NIH HHS R01 GM047795NIGMS NIH HHS R01 GM077548NIGMS NIH HHS R24 GM093901
6 · The paper itself

Abstract

unlabelledNewly emerging human viruses such as Ebola virus, severe acute respiratory syndrome (SARS) virus, and HIV likely originate within an extant population of viruses in nonhuman hosts and acquire the ability to infect and cause disease in humans. Although several mechanisms preventing viral infection of particular hosts have been described, the mechanisms and constraints on viral host expansion are ill defined. We describe here mycobacteriophage Patience, a newly isolated phage recovered using Mycobacterium smegmatis mc(2)155 as a host. Patience has genomic features distinct from its M. smegmatis host, including a much lower GC content (50.3% versus 67.4%) and an abundance of codons that are rarely used in M. smegmatis. Nonetheless, it propagates well in M. smegmatis, and we demonstrate the use of mass spectrometry to show expression of over 75% of the predicted proteins, to identify new genes, to refine the genome annotation, and to estimate protein abundance. We propose that Patience evolved primarily among lower-GC hosts and that the disparities between its genomic profile and that of M. smegmatis presented only a minimal barrier to host expansion. Rapid adaptions to its new host include recent acquisition of higher-GC genes, expression of out-of-frame proteins within predicted genes, and codon selection among highly expressed genes toward the translational apparatus of its new host. IMPORTANCE: The mycobacteriophage Patience genome has a notably lower GC content (50.3%) than its Mycobacterium smegmatis host (67.4%) and has markedly different codon usage biases. The viral genome has an abundance of codons that are rare in the host and are decoded by wobble tRNA pairing, although the phage grows well and expression of most of the genes is detected by mass spectrometry. Patience thus has the genomic profile of a virus that evolved primarily in one type of host genetic landscape (moderate-GC bacteria) but has found its way into a distinctly different high-GC environment. Although Patience genes are ill matched to the host expression apparatus, this is of little functional consequence and has not evidently imposed a barrier to migration across the microbial landscape. Interestingly, comparison of expression levels and codon usage profiles reveals evidence of codon selection as the genome evolves and adapts to its new environment.

Indexed as

Genome, ViralBase CompositionCodonMass SpectrometryMycobacteriophagesMycobacterium smegmatisProteomeViral ProteinsVirus ReplicationCodonProteomeViral Proteins

Identifiers

PMID25467442
PMCPMC4324244
OpenAlexW2099952329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.